Board Rejects Challenge Of Blood Clotting Protein Patent In Final Decision
ALEXANDRIA, Va. — Allegations that a claimed method for improving the viral safety of liquid compositions comprising “Factor VII” (FVII) — a protein involved in the blood clotting process — is...To view the full article, register now.
Already a subscriber? Click here to view full article